Stocks and Investing
Stocks and Investing
Mon, October 16, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yifeng Liu Downgraded (BNTX) to Hold and Decreased Target to $111 on, Oct 16th, 2023
Yifeng Liu of HSBC, Downgraded "BioNTech SE" (BNTX) to Hold and Decreased Target from $124 to $111 on, Oct 16th, 2023.
Yifeng has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 1 agrees with Yifeng's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Korn of "Morgan Stanley" Maintained at Hold with Decreased Target to $116 on, Tuesday, August 8th, 2023
These are the ratings of the 3 analyists that currently disagree with Yifeng
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Monday, August 28th, 2023
- Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $124 on, Friday, July 14th, 2023
- Bill Selesky of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $203 on, Friday, June 16th, 2023
Contributing Sources